Wang Mo, Zheng Chang, Zhou Fan, Ying Xie, Zhang Xiaoqi, Peng Chunyan, Wang Lei
Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, People's Republic of China.
J Gastroenterol Hepatol. 2025 Mar;40(3):666-676. doi: 10.1111/jgh.16826. Epub 2024 Nov 25.
Inflammatory bowel disease (IBD) is an inflammatory disease that occurs to the intestinal tract. Many patients with IBD often develop anemia and often receive oral iron supplementation. Many of them develop non-compliance with oral iron therapy, but the mechanisms are not well understood. We interrogated whether colonic epithelial iron overload impacts cell viability and disease severity. We observed increased expression of iron importers and iron accumulation in mature colonocytes in dextran sulfate sodium (DSS)-induced acute colitis and in humans with active colitis. Administration of hepcidin increased epithelial iron overload and aggravated colonic inflammation in DSS-treated mice and IL10 mice. Hepcidin-induced iron accumulation increased colonic epithelial death, which was prevented by treatment with Trolox, a vitamin E analog and a scavenger of lipid peroxides. By using cultured Caco-2 cells, we showed that iron and inflammatory cytokines (TNF-α and IL-1β) induced a synergistic increase in the number of necrotic cells. We then showed that the combined treatment by hepcidin and cytokines increased labile iron content and lipid peroxidation in Caco-2 cells. Moreover, liproxstatin-1, a ferroptosis inhibitor, and deferoxamine, an iron chelator, both abolished the hepcidin/cytokines induced death of Caco-2 cells, suggesting ferroptosis. We further elucidated that inflammatory cytokines promote lipid peroxidation and ferroptosis by inducing NOX1-dependent exhaustion of reduced glutathione (GSH). Collectively, our findings demonstrate that the inflammatory context predisposes colonic epithelial cells to iron overload mediated ferroptosis, exacerbating colonic inflammation.
炎症性肠病(IBD)是一种发生在肠道的炎症性疾病。许多IBD患者常出现贫血,且常接受口服铁剂补充治疗。他们中的许多人出现口服铁剂治疗依从性差的情况,但其机制尚不清楚。我们探究了结肠上皮铁过载是否会影响细胞活力和疾病严重程度。我们观察到在葡聚糖硫酸钠(DSS)诱导的急性结肠炎小鼠以及活动期结肠炎患者的成熟结肠细胞中,铁转运蛋白表达增加且有铁蓄积。在DSS处理的小鼠和IL10小鼠中,给予铁调素会增加上皮铁过载并加重结肠炎症。铁调素诱导的铁蓄积增加了结肠上皮细胞死亡,而用维生素E类似物、脂质过氧化物清除剂托洛克斯治疗可预防这种情况。通过使用培养的Caco-2细胞,我们发现铁和炎性细胞因子(TNF-α和IL-1β)协同增加了坏死细胞数量。然后我们表明,铁调素和细胞因子联合处理增加了Caco-2细胞中的不稳定铁含量和脂质过氧化。此外,铁死亡抑制剂脂氧素A1和铁螯合剂去铁胺均消除了铁调素/细胞因子诱导的Caco-2细胞死亡,提示存在铁死亡。我们进一步阐明,炎性细胞因子通过诱导NOX1依赖性还原型谷胱甘肽(GSH)耗竭来促进脂质过氧化和铁死亡。总体而言,我们的研究结果表明,炎症环境使结肠上皮细胞易发生铁过载介导的铁死亡,从而加剧结肠炎症。